{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:59:17Z","timestamp":1793109557975,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003958","name":"Technology Foundation STW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1173880"],"award-info":[{"award-number":["APP1173880"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003061","name":"Erasmus Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016993","name":"Ministry of Infrastructure and Water Management","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ymthe.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T19:35:32Z","timestamp":1718652932000},"page":"2519-2534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in\u00a0vivo"],"prefix":"10.1016","volume":"32","author":[{"given":"Tessy A.H.","family":"Hick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Geertsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"van Oosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Abbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Dumenil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.M.","family":"van Kuppeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn A.","family":"Langereis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rawle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"van Oers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Suhrbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-0408","authenticated-orcid":false,"given":"Gorben P.","family":"Pijlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.06.019_bib1","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/s41467-022-31005-z","article-title":"Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection","volume":"13","author":"Rappaport","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.06.019_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101823","article-title":"COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2","volume":"56","author":"Szubert","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.06.019_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12010138","article-title":"Self-amplifying RNA vaccine candidates: alternative platforms for mRNA vaccine development","volume":"12","author":"Schmidt","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2024.06.019_bib5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.tibtech.2023.05.007","article-title":"Rise of the RNA machines\u00a0\u2013 self-amplification in mRNA vaccine design","volume":"41","author":"Comes","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib6","article-title":"Environmental assessment for the emergency use of Harrisvaccines' unlicensed porcine epidemic diarrhea vaccine","year":"2014","journal-title":"iPED+"},{"key":"10.1016\/j.ymthe.2024.06.019_bib7","unstructured":"United States Department of Agriculture. Center for veterinary biologics notice No 17-01. (https:\/\/www.aphis.usda.gov\/animal_health\/vet_biologics\/publications\/notice_17_01.pdf)."},{"key":"10.1016\/j.ymthe.2024.06.019_bib8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11250-020-02270-1","article-title":"Field trials evaluating the efficacy of porcine epidemic diarrhea vaccine, RNA (Harrisvaccine) in the Philippines","volume":"52","author":"Sawattrakool","year":"2020","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.ymthe.2024.06.019_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12026-023-09373-5","article-title":"An assessment of the strategy and status of COVID-19 vaccination in India","volume":"71","author":"Gupta","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.06.019_bib11","unstructured":"Gennova. Lyophilized mRNA vaccine for Injection (https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadSmPC\/4.%20GEMCOVAC%20mRNA%20vaccine%20of%20Gennova_SmPC,%20factsheet%20&%20PI.pdf)."},{"key":"10.1016\/j.ymthe.2024.06.019_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-023-03859-w","article-title":"Self-copying RNA vaccine wins first full approval: what\u2019s next?","author":"Dolgin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.06.019_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41417-023-00587-1","article-title":"Clinical trials of self-replicating RNA-based cancer vaccines","volume":"30","author":"Morse","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2024.06.019_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib16","series-title":"Special Immunizations Program","article-title":"U.S. Army Medical Materiel Development Activity","year":"2023"},{"key":"10.1016\/j.ymthe.2024.06.019_bib17","series-title":"EQUIVAC TC-83","author":"M\u00e9xico","year":"2018"},{"key":"10.1016\/j.ymthe.2024.06.019_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0042-6822(89)90539-4","article-title":"Evidence that Sindbis virus NSP2 is an autoprotease which processes the virus nonstructural polyprotein","volume":"171","author":"Ding","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2024.06.019_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2024.06.019_bib20","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/jvi.68.3.1874-1885.1994","article-title":"Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis","volume":"68","author":"Shirako","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib21","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/j.1460-2075.1994.tb06587.x","article-title":"Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis","volume":"13","author":"Lemm","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2024.06.019_bib22","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/JVI.75.8.3509-3519.2001","article-title":"Sequence requirements for Sindbis virus subgenomic mRNA promoter function in cultured cells","volume":"75","author":"Wielgosz","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1099\/vir.0.020081-0","article-title":"Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle","volume":"91","author":"Kamrud","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib24","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.85.16.5997","article-title":"Western equine encephalitis virus is a recombinant virus","volume":"85","author":"Hahn","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.06.019_bib25","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1038\/s41598-017-07152-5","article-title":"Emergence of recombinant Mayaro virus strains from the Amazon basin","volume":"7","author":"Mavian","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.06.019_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ympev.2015.01.016","article-title":"Evidence for homologous recombination in Chikungunya Virus","volume":"85","author":"Casal","year":"2015","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib27","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1128\/jvi.70.8.5153-5164.1996","article-title":"Nonhomologous RNA-RNA recombination events at the 3' nontranslated region of the Sindbis virus genome: hot spots and utilization of nonviral sequences","volume":"70","author":"Hajjou","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib28","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/jvi.71.4.2693-2704.1997","article-title":"RNA-RNA recombination in Sindbis virus: roles of the 3' conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching","volume":"71","author":"Hill","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep36317","article-title":"Experimental piscine alphavirus RNA recombination in\u00a0vivo yields both viable virus and defective viral RNA","volume":"6","author":"Petterson","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.06.019_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007706","article-title":"RNA recombination at Chikungunya virus 3'UTR as an evolutionary mechanism that provides adaptability","volume":"15","author":"Filomatori","year":"2019","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00731-20","article-title":"Differential Alphavirus Defective RNA Diversity between Intracellular and Extracellular Compartments Is Driven by Subgenomic Recombination Events","volume":"11","author":"Langsjoen","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2024.06.019_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008825","article-title":"Cross-utilisation of template RNAs by alphavirus replicases","volume":"16","author":"Lello","year":"2020","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v12060660","article-title":"A Low Fidelity Virus Shows Increased Recombination during the Removal of an Alphavirus Reporter Gene","volume":"12","author":"Kautz","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.06.019_bib34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib35","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/j.vaccine.2016.04.060","article-title":"Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains","volume":"34","author":"Condit","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses -an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cels.2020.12.005","article-title":"Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion","volume":"12","author":"Singer","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.ymthe.2024.06.019_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241592","article-title":"Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2","volume":"15","author":"Boussier","year":"2020","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2024.06.019_bib39","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.vaccine.2024.03.032","article-title":"Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens","volume":"42","author":"Comes","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib40","article-title":"Venezuelan equine encephalitis virus non-structural protein 3 dictates superinfection exclusion in mammalian cells","author":"Hick","year":"2024","journal-title":"Res. Square"},{"key":"10.1016\/j.ymthe.2024.06.019_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/v11030253","article-title":"Packaging of genomic RNA in positive-sense single-stranded RNA viruses: A complex story","volume":"11","author":"Comas-Garcia","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.06.019_bib42","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00644-11","article-title":"Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution","volume":"85","author":"Kim","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib43","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1128\/JVI.01506-12","article-title":"Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci","volume":"86","author":"Fros","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib44","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/JVI.03612-14","article-title":"Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication","volume":"89","author":"Scholte","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00838-18","article-title":"Multiple host factors interact with the hypervariable domain of chikungunya virus nsP3 and determine viral replication in cell-specific mode","volume":"92","author":"Meshram","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005810","article-title":"New World and Old World alphaviruses have evolved to exploit different components of stress granules, FXR and G3BP proteins, for assembly of viral replication complexes","volume":"12","author":"Kim","year":"2016","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/JVI.74.2.914-922.2000","article-title":"Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis","volume":"74","author":"MacDonald","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/vim.2006.0090","article-title":"Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells","volume":"20","author":"Nishimoto","year":"2007","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib49","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.vaccine.2012.04.030","article-title":"Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles","volume":"30","author":"Tonkin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006788","article-title":"Lower temperatures reduce type I interferon activity and promote alphaviral arthritis","volume":"13","author":"Prow","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1092370","article-title":"Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL\/6J mouse model","volume":"13","author":"Bishop","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/vaccines8020209","article-title":"Arthritogenic alphavirus vaccines: Serogrouping versus cross-protection in mouse models","volume":"8","author":"Nguyen","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.06.019_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003354","article-title":"Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection","volume":"8","author":"Poo","year":"2014","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2024.06.019_bib54","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1128\/JVI.00956-12","article-title":"Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock","volume":"86","author":"Rudd","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139481","article-title":"Infectious chikungunya virus in the saliva of mice, monkeys and humans","volume":"10","author":"Gardner","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2024.06.019_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00294-21","article-title":"Host-virus chimeric events in SARS-CoV-2-infected cells are infrequent and artifactual","volume":"95","author":"Yan","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1423-0410.2011.01536.x","article-title":"Duration of Ross River viraemia in a mouse model--implications for transfusion transmission","volume":"102","author":"Shang","year":"2012","journal-title":"Vox Sang."},{"key":"10.1016\/j.ymthe.2024.06.019_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/v14061239","article-title":"Recombination in coronaviruses, with a focus on SARS-CoV-2","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.06.019_bib59","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-023-38435-3","article-title":"Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants","volume":"14","author":"Tamura","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.06.019_bib60","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1128\/JVI.00297-14","article-title":"Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture","volume":"88","author":"Wicht","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib61","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1128\/JVI.00356-15","article-title":"A single point mutation creating a furin cleavage site in the spike protein renders porcine epidemic diarrhea coronavirus trypsin independent for cell entry and fusion","volume":"89","author":"Li","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0378-1135(88)90033-8","article-title":"Clinical and virological observations on swine experimentally infected with Getah virus","volume":"16","author":"Kumanodmido","year":"1988","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14712598.6.2.135","article-title":"Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications","volume":"6","author":"Pijlman","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.019_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104648","article-title":"Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats","volume":"113","author":"Stokes","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib65","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s00253-020-10437-x","article-title":"Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection","volume":"104","author":"Kumar","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006155","article-title":"RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation","volume":"13","author":"Wilson","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s13071-016-1838-1","article-title":"Chikungunya virus transmission between Aedes albopictus and laboratory mice","volume":"9","author":"Hugo","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ymthe.2024.06.019_bib68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3201\/eid2802.204887","article-title":"Group IV getah virus in Culex mosquitoes, Malaysia","volume":"28","author":"Sam","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.06.019_bib69","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3390\/v7072795","article-title":"Tissue barriers to arbovirus infection in mosquitoes","volume":"7","author":"Franz","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.06.019_bib70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41584-019-0276-9","article-title":"Rheumatic manifestations of chikungunya: emerging concepts and interventions","volume":"15","author":"Suhrbier","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib71","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1128\/jvi.69.12.7391-7401.1995","article-title":"Genesis of Sindbis virus by in\u00a0vivo recombination of nonreplicative RNA precursors","volume":"69","author":"Raju","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib72","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1128\/JVI.77.19.10394-10403.2003","article-title":"An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector","volume":"77","author":"Perri","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib73","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1128\/JVI.01282-07","article-title":"Identification and characterization of interferon-induced proteins that inhibit alphavirus replication","volume":"81","author":"Zhang","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib74","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1017\/S135583820101010X","article-title":"Cis-acting RNA elements at the 5' end of Sindbis virus genome RNA regulate minus- and plus-strand RNA synthesis","volume":"7","author":"Frolov","year":"2001","journal-title":"RNA"},{"key":"10.1016\/j.ymthe.2024.06.019_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.aivir.2021.07.003","article-title":"Alphavirus RNA replication in vertebrate cells","volume":"111","author":"Ahola","year":"2021","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ymthe.2024.06.019_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83042","article-title":"Architecture of the chikungunya virus replication organelle","volume":"11","author":"Laurent","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.06.019_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2020.12.007","article-title":"Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles","volume":"556","author":"Mihelc","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2024.06.019_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054523","article-title":"COVID-19 Biogenesis and Intracellular Transport","volume":"24","author":"Mironov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.06.019_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virusres.2013.07.006","article-title":"Identification and characterisation of a highly divergent geminivirus: Evolutionary and taxonomic implications","volume":"177","author":"Bernardo","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.ymthe.2024.06.019_bib80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/v12030299","article-title":"Co-Acquired Nanovirus and Geminivirus Exhibit a Contrasted Localization within Their Common Aphid Vector","volume":"12","author":"Di Mattia","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.06.019_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005883","article-title":"A bat-derived putative cross-family recombinant coronavirus with a reovirus gene","volume":"12","author":"Huang","year":"2016","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib82","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41467-024-44872-5","article-title":"LDLR is used as a cell entry receptor by multiple alphaviruses","volume":"15","author":"Zhai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.06.019_bib83","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-021-23779-5","article-title":"A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses","volume":"12","author":"Amarilla","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.06.019_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00222-19","article-title":"Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I interferon","volume":"93","author":"Visser","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005654","article-title":"Mosquito co-infection with Zika and chikungunya virus allows simultaneous transmission without affecting vector competence of Aedes aegypti","volume":"11","author":"G\u00f6ertz","year":"2017","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2024.06.019_bib86","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9100848","article-title":"Sequencing of historical isolates, K-mer mining and high serological cross-reactivity with Ross River virus argue against the presence of getah virus in Australia","volume":"9","author":"Rawle","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2024.06.019_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70207","article-title":"Widespread discrepancy in Nnt genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies","volume":"11","author":"Rawle","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2024.06.019_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010867","article-title":"Mouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression","volume":"18","author":"Bishop","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2024.06.019_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.160163","article-title":"Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19","volume":"859","author":"Dumenil","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ymthe.2024.06.019_bib91","article-title":"A yellow fever virus 17D infection and disease mouse model used to evaluate a chimeric Binjari-yellow fever virus vaccine","volume":"8","author":"Yan","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.06.019_bib92","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","article-title":"First-in-human phase I clinical trial of an SFV-based RNA replicon cancer vaccine against HPV-induced cancers","volume":"29","author":"Komdeur","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.06.019_bib93","first-page":"P4444","article-title":"Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: Comparison of immune responses in stage III and stage IV patients","volume":"3","author":"Morse","year":"2015","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.06.019_bib94","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib95","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/CVI.00258-12","article-title":"Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults","volume":"19","author":"Wecker","year":"2012","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib96","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41591-022-01937-6","article-title":"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results","volume":"28","author":"Palmer","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.06.019_bib97","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.06.019_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101262","article-title":"Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial","volume":"44","author":"Pollock","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2024.06.019_bib99","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ymthe.2022.01.001","article-title":"A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models","volume":"30","author":"Maruggi","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624004015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T02:52:31Z","timestamp":1763779951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624004015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1525001624004015"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}